Assessment of the impact of a memory enhancer traditional oral formulation in management of dementia, a randomized controlled clinical trial.
Phase 3
Recruiting
- Conditions
- alzheimer disease.Other degenerative disorders of nervous system in diseases classified elsewhere
- Registration Number
- IRCT20191212045709N3
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
diagnosis of dementia based on DSM criteria
Exclusion Criteria
patients with cardiovascular disease
pregnancy
breast feeding
sensitivity to herbal medicines present in formulation
patients with depression
patients with peptic ulcer disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TSH serum level. Timepoint: every 6 months. Method of measurement: serum sample.;B12 serum level. Timepoint: every 6 months. Method of measurement: serum sample.
- Secondary Outcome Measures
Name Time Method